Inno4Vac is a public-private partnership that addresses scientific bottlenecks in vaccine development.
It proposes to develop predictive biological and mathematical models of vaccine performance and bio-manufacturing.
Artificial intelligence combined with big data and computational modelling will be used to build an open-access and cloud-based platform for in silico vaccine efficacy assessment and development. Controlled human infection models and cell-based human in vitro 3D models will be developed to enable early evaluation of vaccine efficacy and prediction of immune protection.
Finally, for vaccine bio-manufacturing the goal is to establish an open source in silico simulation platform for guiding the production of vaccine candidates and associated stability testing.
At a glance
innovations to accelerate vaccine development and manufacture
